ArticlePediatric nephrology (Berlin, Germany)2026
An uncommon culprit: PPI-induced acute tubulointerstitial nephritis in a teenager.
Article in Pediatric nephrology (Berlin, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Proton pump inhibitor (PPI)-induced acute tubulointerstitial nephritis (ATIN) is rarely recognized in children. A 16-year-old boy presented with a 2-month history of vomiting, abdominal pain, and weight loss and had received PPIs repeatedly. He had elevated creatinine, metabolic acidosis, sterile pyuria, glucosuria, and markedly increased urine β2-microglobulin. Ultrasound showed enlarged echogenic kidneys. Despite hydration, kidney function did not improve. Kidney biopsy revealed T lymphocyte-predominant tubulointerstitial inflammation with eosinophils, consistent with hypersensitivity-mediated ATIN due to PPI use. He recovered fully with corticosteroids and cessation of PPI use. Concurrent Helicobacter pylori gastritis was treated with a PPI-free eradication regimen. This case highlights the importance of considering PPI-associated ATIN in unexplained pediatric AKI.
Indexed as
Identifiers
41697341What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.